Objective: To review the literature on and provide evidence-based recommendations for management of HIV/ hepatitis B (HBV) coinfection. Methods: Review of the literature for clinical trials, guidelines, and cohort studies on HIV/HBV disease management. Results: HIV patients should be evaluated for viral hepatitis. Those who do not have evidence of immunity should be vaccinated and monitored for response. Those who have HIV/HBV should have additional serologies checked to evaluate for hepatitis B e antigen status and level of viremia. All HIV/HBV coinfected patients should be started on antiretroviral therapy with tenofovir-based regimens. Those with HIV/HBV and cirrhosis should be screened for hepatocellular cancer every 6 months. Conclusion: HIV patients should be vaccinated against hepatitis B; those with coinfection should be treated for both viruses. It is important to monitor for treatment response to both HIV and HBV and liver disease complications.
|Original language||English (US)|
|Journal||Journal of Clinical Outcomes Management|
|State||Published - Oct 1 2017|
- Substance abuse treatment
ASJC Scopus subject areas
- Health Policy